(redirected from Neurofibromatosis Type 1)
NF-1Neurofibromatosis Type 1
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
In the past, the company said Mirdametinib received US FDA Orphan Drug Designation for the treatment of neurofibromatosis type 1 and Fast Track Designation for the treatment of patients >= two years of age with neurofibromatosis type 1-associated inoperable plexiform neurofibromas.
Neurofibromatosis type 1 associated with pheochromocytoma and gastrointestinal stromal tumors: A case report and literature review.
(3.) Adams W, Mitchell L, Candelana-Santiago R, Hefner J, Gramling J Concurrent Ulcerative Colitis and Neurofibromatosis Type 1 The Question of a Common Pathway Pediatrics 2016, 137 e20150973.
The word schwannoma is not usually associated with either the optic nerve or neurofibromatosis type 1. The origin of the optic nerve as a derivative of the central nervous system precludes the formation of schwannomas in this structure.
Pheochromocytoma can be seen as a component of cancer susceptibility syndromes such as multiple endocrine neoplasia (MEN) Types 2A and 2B (RET mutation), von-Hippel Lindau syndrome (VHL mutation), neurofibromatosis Type 1 (NF1 mutation) and Familial Paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD mutations) (5,6).
Neurofibromatosis type 1 (NF-1), or von Recklinghausen disease, is the most common and is a result of a genetic mutation on chromosome 17 that is involved in producing a protein called neurofibromin.
From 2005 to 2010, 20 consecutive patients with fully manifested neurofibromatosis type 1 (NF1) underwent elective neurofibroma resection at our institution (Departments of Plastic Surgery and of Odontostomatology).
Stephenson, "Recent developments in neurofibromatosis type 1," Current Opinion in Neurology, vol.
This was an uncommon case of the identification of jugular foramen meningocele in a neurofibromatosis type 1 patient.
A broad range of vascular abnormalities can be seen in patients with neurofibromatosis type 1 including midaortic syndrome, which is characterized by severe narrowing of the abdominal aorta, usually involving the renal arteries and visceral branches [4].